References
- Raychaudhuri, S. P.; Farber, E. M. The Prevalence of Psoriasis in the World. J. Eur. Acad. Dermatol. Venereol. 2001, 15, 16–17. DOI: https://doi.org/10.1046/j.1468-3083.2001.00192.x.
- Sticherling, M.;. Mechanisms of Psoriasis. Drug Discov. Today Dis. Mech. 2005, 2, 275–281. Doi:https://doi.org/10.1016/j.ddmec.2005.05.019.
- Shehata, W. A.; Maraee, A. H.; Abdo, E. E.; Hemida, A. S. Role of CYR61 in Psoriatic Lesional and Perilesional Skin: A Clinical and Immunohistochemical Study. J. Cosmet. Dermatol. 2021, Epub ahead of print. doi:https://doi.org/10.1111/jocd.13947
- Voiculescu, V. M.; Lupu, M.; Papagheorghe., L.; Giurcaneanu, C.; Micu, E. Psoriasis and Metabolic Syndrome–scientific Evidence and Therapeutic Implications. J. Med. Life. 2014, 4, 468–471. PMID: 25713604; PMCID: PMC4316120.
- Ogawa, E.; Sato, Y.; Minagawa, A.; Okuyama, R. Pathogenesis of Psoriasis and Development of Treatment. J. Dermatol. 2018, 45, 264–272. DOI: https://doi.org/10.1111/1346-8138.14139.
- Baker, B. S.; Ovigne, J. M.; Powles, A. V.; Corcoran, S.; Fry, L. Normal Keratinocytes Express Toll‐like Receptors (Tlrs) 1, 2 and 5: Modulation of TLR Expression in Chronic Plaque Psoriasis. Br. J. Dermatol. 2003, 148, 670–679. DOI: https://doi.org/10.1046/j.1365-2133.2003.05287.x.
- Franchi, L.; Warner, N.; Viani, K.; Nuñez, G. Function of Nod‐like Receptors in Microbial Recognition and Host Defense. Immunol. Rev. 2009, 227, 106–128. DOI: https://doi.org/10.1111/j.1600-065X.2008.00734.x.
- Mahla, R. S.; Reddy, M. C.; Prasad, D. V.; Sweeten, K. H. PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology. Front. Immunol. 2013, 4, 248. DOI: https://doi.org/10.3389/fimmu.2013.00248.
- Chen, G.; Shaw, M. H.; Kim, Y. G.; Nuñez, G. NOD-like Receptors: Role in Innate Immunity and Inflammatory Disease. Ann. Rev. Pathol. 2009, 4, 365–398. DOI: https://doi.org/10.1146/annurev.pathol.4.110807.092239.
- Fernandes, R.; Tsuda, C.; Perumalsamy, A. L.; Naranian, T.; Chong, J.; Acton, B. M.; Tong, Z. B.; Nelson, L. M.; Jurisicova, A. NLRP5 Mediates Mitochondrial Function in Mouse Oocytes and Embryos. Biol. Reprod. 2012, 138, 1–10. DOI: https://doi.org/10.1095/biolreprod.111.093583.
- Correa, R. G.; Milutinovic, S.; Reed, J. C. Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in Innate Immunity and Inflammatory Diseases. Biosci. Rep. 2012, 6, 597–608. DOI: https://doi.org/10.1042/BSR20120055.
- Hugot, J. P.; Chamaillard, M.; Zouali, H.; Lesage, S.; Cézard, J. P.; Belaiche, J.; Almer, S.; Tysk, C.; O’Morain, C. A.; Gassull, M.;, et al. Association of NOD2 Leucine-rich Repeat Variants with Susceptibility to Crohn’s Disease. Nature 2001, 411, 599–603. DOI: https://doi.org/10.1038/35079107.
- Miceli-Richard, C.; Lesage, S.; Rybojad, M.; Prieur, A. M.; Manouvrier-Hanu, S.; Häfner, R.; Chamaillard, M.; Zouali, H.; Thomas, G.; Hugot, J. P. CARD15 Mutations in Blau Syndrome. Nat. Genet. 2001, 29, 19–20. DOI: https://doi.org/10.1038/ng720.
- Macaluso, F.; Nothnagel, M.; Parwez, Q.; Petrasch-Parwez, E.; Bechara, F. G.; Epplen, J. T.; Hoffjan, S. Polymorphisms in NACHT-LRR (NLR) Genes in Atopic Dermatitis. Exp Dermatol. 2007, 16, 692–698. DOI: https://doi.org/10.1111/j.1600-0625.2007.00589.x.
- Kanazawa, N.; Okafuji, I.; Kambe, N.; Nishikomori, R.; Nakata-Hizume, M.; Nagai, S.; Fuji, A.; Yuasa, T.; Manki, A.; Sakurai, Y., et al. Early-onset Sarcoidosis and CARD15 Mutations with Constitutive Nuclear factor-kappaB Activation: Common Genetic Etiology with Blau Syndrome. Blood 2005, 105, 1195–1197. DOI: https://doi.org/10.1182/blood-2004-07-2972.
- Przekop, P. R.; Tulgan, H.; Przekop, A. A.; Glantz, M. Adverse Drug Reaction to Methotrexate: Pharmacogenetic Origin. J. Am. Osteopath. Assoc. 2006, 106(12), 706–707.
- Carretero, G.; Ribera, M.; Belinchón, I.; Carrascosa, J. M.; Puig, L.; Ferrandiz, C.; Dehesa, L.; Vidal, D.; Peral, F.; Jorquera, E.; et al. Psoriasis Group of the AEDV. Guidelines for the Use of Acitretin in Psoriasis. Psoriasis Group of the Spanish Academy of Dermatology and Venereology. Actas Dermosifiliogr. 2013 Sep, 104(7), 598–616. doi:https://doi.org/10.1016/j.adengl.2013.01.001. Epub 2013 Jul 23. PMID: 23891453
- Ramos-Vara, J. A.;. Technical Aspects of Immunohistochemistry. Vet. Pathol. 2005, 42, 405–426. DOI: https://doi.org/10.1354/vp.42-4-405.
- Smyth, J. F.; Gourley, C.; Walker, G.; MacKean, M. J.; Stevenson, A.; Williams, A. R.; Nafussi, A. A.; Rye, T.; Rye, R.; Stewart, M.;, et al. Antiestrogen Therapy Is Active in Selected Ovarian Cancer Cases: The Use of Letrozole in Estrogen Receptor-positive Patients. Clin. Cancer. Res. 2007, 15, 3617–3622. DOI: https://doi.org/10.1158/1078-0432.CCR-06-2878.
- Mazières, J.; Brugger, W.; Cappuzzo, F.; Middel, P.; Frosch, A.; Bara, I.; Klingelschmitt, G.; Klughammer, B. Evaluation of EGFR Protein Expression by Immunohistochemistry Using H-score and the Magnification Rule: Re-analysis of the SATURN Study. Lung Cancer. 2013, 82, 231–237. DOI: https://doi.org/10.1016/j.lungcan.2013.07.016.
- Takeo, M.; Lee, W.; Ito, M. Wound Healing and Skin Regeneration. Cold Spring Harb. Perspect. Med. 2015 Jan 5, 5(1), a023267. DOI: https://doi.org/10.1101/cshperspect.a023267.
- Llamas-Velasco, M.; de la Cueva, P.; Notario, J.; Martínez-Pilar, L.; Martorell, A.; Moreno-Ramírez, D. Moderate Psoriasis: A Proposed Definition. Actas Dermosifiliogr. 2017, 108, 911–917. English, Spanish. DOI: https://doi.org/10.1016/j.ad.2017.07.002.
- Langley, R. G.; Ellis, C. N. Evaluating Psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician’s Global Assessment. J. Am. Acad. Dermatol. 2004, 51, 563–569. DOI: https://doi.org/10.1016/j.jaad.2004.04.012.
- Krueger, J. G.;. The Immunologic Basis for the Treatment of Psoriasis with New Biologic Agents. J. Am. Acad. Dermatol. 2002, 46, 1–23; quiz 23–6. DOI: https://doi.org/10.1067/mjd.2002.120568.
- Kufer, T. A.; Sansonetti, P. J. NLR Functions beyond Pathogen Recognition. Nat. Immunol. 2011, 12, 121–128. DOI: https://doi.org/10.1038/ni.1985.
- Tervaniemi, M. H.; Katayama, S.; Skoog, T.; Siitonen, H. A.; Vuola, J.; Nuutila, K.; Sormunen, R.; Johnsson, A.; Linnarsson, S.; Suomela, S.;, et al. NOD-like Receptor Signaling and Inflammasome-related Pathways are Highlighted in Psoriatic Epidermis. Sci. Rep. 2016, 15(6), 22745. DOI: https://doi.org/10.1038/srep22745.
- Latz, E.; Xiao, T. S.; Stutz, A. Activation and Regulation of the Inflammasomes. Nat. Rev. Immunol. 2013, 13, 397–411. DOI: https://doi.org/10.1038/nri3452.
- Zhu, K.; Yin, X.; Tang, X.; Zhang, F.; Yang, S.; Zhang, X. Meta-analysis of NOD2/CARD15 Polymorphisms with Psoriasis and Psoriatic Arthritis. Rheumatol. Int. 2012, 32, 1893–1900. DOI: https://doi.org/10.1007/s00296-011-1813-2.
- Mitsui, H.; Suárez-Fariñas, M.; Belkin, D. A.; Levenkova, N.; Fuentes-Duculan, J.; Coats, I.; Fujita, H.; Krueger, J. G. Combined Use of Laser Capture Microdissection and cDNA Microarray Analysis Identifies Locally Expressed Disease-related Genes in Focal Regions of Psoriasis Vulgaris Skin Lesions. J. Invest. Dermatol. 2012, 132, 1615–1626. DOI: https://doi.org/10.1038/jid.2012.33.
- Schlessinger, D. I.; Goyal, A.; Belgam Syed, S. Y.; Sonthalia, S.; Embryology, Epidermis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Mar 10. 2021 Jan. PMID: 28722897.
- Mahajan, R.; Handa, S. Pathophysiology of Psoriasis. Indian J. Dermatol. Venereol. Leprol. 2013, 79, 1–9. DOI: https://doi.org/10.4103/0378-6323.115505.
- Qin, M.; Pirouz, A.; Kim, M. H.; Krutzik, S. R.; Garbán, H. J.; Kim, J. Propionibacterium Acnes Induces IL-1β Secretion via the NLRP3 Inflammasome in Human Monocytes. J. Invest. Dermatol. 2014, 134, 381–388. DOI: https://doi.org/10.1038/jid.2013.309.
- Kistowska, M.; Gehrke, S.; Jankovic, D.; Kerl, K.; Fettelschoss, A.; Feldmeyer, L.; Fenini, G.; Kolios, A.; Navarini, A.; Ganceviciene, R.;, et al. IL-1β Drives Inflammatory Responses to Propionibacterium Acnes in Vitro and in Vivo. J. Invest. Dermatol. 2014, 134, 677–685. DOI: https://doi.org/10.1038/jid.2013.438.